Gross Profit for Insulet (PODD)
According to Insulet's latest reported financial statements, the company's current gross profit (TTM) is $1.94B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
PODD
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$1.94B
YoY change
+34.2%
5Y CAGR
+27.2%
Peak year (2025)
$1.94B
Cumulative gross profit
$8.60B
Gross Profit history chart for Insulet (PODD) from 2002 to 2025
Gross Profit history table for Insulet (PODD) from 2002 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $1.94B | +34.2% | ||
| 2024 | $1.45B | +24.6% | ||
| 2023 | $1.16B | +44.0% | ||
| 2022 | $805.60M | +7.1% | ||
| 2021 | $752.10M | +29.2% | ||
| 2020 | $582.30M | +21.2% | ||
| 2019 | $480.30M | +29.8% | ||
| 2018 | $370.17M | +33.6% | ||
| 2017 | $277.17M | +31.3% | ||
| 2016 | $211.09M | +58.4% | ||
| 2015 | $133.27M | -7.0% | ||
| 2014 | $143.29M | +27.5% | ||
| 2013 | $112.40M | +21.7% | ||
| 2012 | $92.34M | +38.4% | ||
| 2011 | $66.71M | +52.6% | ||
| 2010 | $43.73M | +139.0% | ||
| 2009 | $18.30M | -499.1% | ||
| 2008 | -$4.58M | -62.9% | ||
| 2007 | -$12.36M | +3.0% | ||
| 2006 | -$12.00M | +710.6% | ||
| 2005 | -$1.48M | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — |
Gross Profit values are taken from Insulet's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Insulet (PODD) most recent annual gross profit stands at $1.94B (2025) – surged 34.2% year-over-year.
Through 2020–2025 (5 years), Insulet gross profit delivered a +27.2% annualised rate; sustaining 10 straight years of year-over-year growth.
$1.94B stands as the all-time-high annual gross profit, posted in 2025, against a low of -$12.36M during 2007.
Insulet (PODD) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $53.80B.
Insulet Gross Profit by Year
Insulet Gross Profit 2025: $1.94B
Insulet gross profit in 2025 was $1.94B, surged 34.2% from 2024. This figure represents the highest annual value in the available history.
Insulet Gross Profit 2024: $1.45B
Insulet gross profit in 2024 was $1.45B, grew 24.6% from 2023.
Insulet Gross Profit 2023: $1.16B
Insulet gross profit in 2023 was $1.16B, surged 44.0% from 2022.
Insulet Gross Profit 2022: $805.60M
Insulet gross profit in 2022 was $805.60M, grew 7.1% from 2021.
Insulet Gross Profit 2021: $752.10M
Insulet gross profit in 2021 was $752.10M.
See more financial history for Insulet (PODD).
Sector peers — Gross Profit
Companies in the same sector as Insulet, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Insulet's gross profit?
- Latest reported gross profit for Insulet (PODD) is $1.94B (period ending December 31, 2025).
How has Insulet gross profit changed year-over-year?
- Insulet (PODD) gross profit changed +34.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Insulet gross profit?
- Insulet (PODD) gross profit compound annual growth rate is +27.2% over the most recent 5 years available.
When did Insulet gross profit hit its highest annual value?
- Insulet gross profit reached its highest annual value of $1.94B in 2025.
What was Insulet gross profit in 2024?
- Insulet (PODD) gross profit in 2024 was $1.45B.
What was Insulet gross profit in 2025?
- Insulet (PODD) gross profit in 2025 was $1.94B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PODD Overview
Company profile, financial tools, and key metrics
PODD Revenue Counter
Earns $85.88 every second. See per minute, hour, and day.
PODD Earnings Counter
Earns $7.84 per second net profit. See per minute, hour, and day.
PODD Economic Scale
Exceeds St. Lucia's GDP. Compare with world economies.
PODD What If Invested
What if you had invested $1,000? See historical returns from any date.
PODD How It Makes Money
Discover visual breakdown of $2.71B in revenue — where it comes from and where it goes.
PODD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PODD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PODD Daily Price Character
Explosive · 51.5% historical win rate (green days). Streaks & record days.
PODD Buybacks
0.30% TTM buyback yield. Shareholder yield & SBC comparison.